샘플 요청 목록

 카트 문의
시장보고서
상품코드
1739196

세계의 내츄럴 API 시장

Natural APIs
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 288 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 내츄럴 API 시장은 2030년까지 408억 달러에 이를 전망

2024년에 309억 달러로 추정되는 내츄럴 API 세계 시장은 2024-2030년간 CAGR 4.8%로 성장하여 2030년에는 408억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 알카로이드는 CAGR 5.8%를 나타내고, 분석 기간 종료시에는 188억 달러에 이를 것으로 예측됩니다. 페놀산 부문의 성장률은 분석 기간에 CAGR 4.4%로 추정됩니다.

미국 시장은 84억 달러로 추정, 중국은 CAGR 8.8%로 성장 예측

미국의 내츄럴 API 시장은 2024년에 84억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 8.8%로 2030년까지 시장 규모가 86억 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.9%와 3.8%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.8%를 보일 것으로 예측됩니다.

세계의 내츄럴 API 시장 - 주요 동향과 촉진요인 정리

천연물 의약품 원료가 현대 의약품 개발에서 전략적 관련성을 되찾고 있는 이유는 무엇일까?

식물, 미생물, 해양자원, 동물에서 유래한 천연 의약품 유효성분(API)은 치료 효과의 입증, 구조의 다양성, 그린 케미스트리 원칙과의 정합성으로 인해 전 세계 의약품 개발에서 부활을 맞이하고 있습니다. 복잡한 유기 합성에 의해 제조되는 완전 합성 원약과 달리, 천연 API는 생물학적 원료에서 추출 및 정제되며, 종종 용매 추출, 초임계 유체법, 발효법 등이 사용됩니다. 이러한 기원은 특히 통증, 종양, 항감염증, 심혈관, 대사 카테고리에서 많은 천연 유래 의약품에 신뢰성과 수용성을 부여하고 있습니다.

역사적으로 볼 때, 파클리탁셀(이치나무 유래), 아르테미시닌(아르테미시아 유래), 로바스타틴(아스페르길루스 테레우스 유래)과 같은 획기적인 의약품은 치료법을 변화시키는 천연 API의 잠재력을 보여주었습니다. 항생제 내성 증가, 암의 복잡성 증가, 신약 개발의 새로운 발판이 필요한 상황에서 천연 API는 순수 합성 라이브러리와는 비교할 수 없는 생물학적 활성 저장소를 제공합니다. 추출 기술, 대사체학 및 계산생물학의 발전으로 인해 1차 약물 또는 반합성 개질을 위한 리드 구조로 제약 파이프라인에 통합하는 것이 활성화되고 있습니다.

조달 전략, 녹색 추출, 규제 발전이 천연 API 개발을 어떻게 강화하는가?

최신 천연 원료의약품 제조는 추적 가능한 조달, 무용매 또는 최소 용매 처리, 공급망 전반의 지속가능성을 중시합니다. 배양 바이오매스, 식물 세포 배양, 해양 양식, 미생물 발효는 일관성을 보장하고, 환경에 미치는 영향을 줄이고, 원료 공급을 안정화하기 위해 사용됩니다. 초임계 CO2 추출, 효소 보조 가수분해, 마이크로파 보조 추출 등의 기술은 수율, 순도 및 환경 준수를 높이기 위해 채택되었습니다.

미국, EU, 일본 및 신흥 시장의 규제 프레임워크는 식물 의약품, 식물 제제 및 전통 의약품 경로를 통해 천연 API를 지원하기 위해 진화하고 있으며, WHO와 EMA의 가이드라인은 현재 품질 관리, 약리학적 특성 평가 및 안전성 검증에 대한 명확한 기대치를 제시하고 있습니다. GMP, ICH Q7 및 약전 모노그래프를 준수할 수 있는 능력은 세계 상업화에 있어 매우 중요해지고 있습니다. 추출물의 표준화, 배치 간 재현성 및 안정성 프로파일링은 기업이 생물학적 활성과 규정 준수를 유지하면서 생산 규모를 확대하고자 하기 때문에 점점 더 많은 관심을 받고 있는 분야입니다.

천연 API 기반 의약품에 대한 수요를 촉진하는 치료 카테고리와 시장은?

천연 API는 종양학, 감염, 염증, 위장 건강, 심장 대사 장애, 피부과에서 높은 수요를 보이고 있습니다. 식물 알칼로이드, 플라보노이드, 사포닌, 테르페노이드는 많은 항암제 및 항염증제의 골격을 형성하고 있습니다. 리팜핀이나 암포테리신 B와 같은 미생물 발효 유래 항생제 및 항진균제는 여전히 감염병 치료에 필수적입니다. 디곡신(디기탈리스 유래)과 같은 순환계 약물과 퀴니네와 같은 항말라리아 약물은 여전히 천연 유래 원약과 그 유사체에 의존하고 있습니다.

아시아태평양은 한약의 전통이 깊게 뿌리내리고 생물다양성이 풍부하기 때문에 여전히 천연물 API의 최대 소비국이자 생산국입니다. 인도와 중국이 수출과 제제화를 독점하고 있으며, 의료용 의약품과 식물 의약품 모두에 원료를 공급하고 있습니다. 북미와 유럽에서는 클린 라벨 의약품, 통합의학, 식물 의약품 개발 측면에서 천연물 API에 대한 수요가 확대되고 있습니다. 미국에서는 식물 경로에 대한 규제 당국의 지원과 천연 유래 의약품에 대한 소비자의 관심이 이러한 성숙한 시장에서 수요를 강화하고 있습니다.

천연 API 시장의 장기적인 성장과 혁신의 원동력은 무엇인가?

천연물 API 시장 성장의 원동력은 천연물 의약품에 대한 수요 증가, 지속가능성 관련 규제, 합성화학의 신약개발 병목현상입니다. 제약사들은 하이스루풋 스크리닝, AI 기반 화합물 마이닝, 민족약리학적 데이터베이스를 통해 천연물 라이브러리를 재검토하고 있습니다. 제약사, 식물 연구기관, 바이오테크 스타트업 간의 협업으로 새로운 스캐폴드, 하이브리드 원료, 전통 화합물의 새로운 치료 적응증을 창출하고 있습니다.

인공 미생물 및 식물 세포를 이용한 천연 API의 생명공학 합성에 대한 투자로 확장성, 환경 관리, 지적 재산권 보호가 가능해졌습니다. 오믹스 기술, 바이오인포매틱스, 분자 도킹의 발전으로 천연물의 리드 화합물 식별과 SAR(구조-활성 상관관계) 모델링이 가속화되고 있습니다. 새로운 치료제에 대한 제약업계의 니즈와 함께 소비자들의 자연 건강법에 대한 선호도가 높아짐에 따라, 천연물 API는 세계 의약품 개발 파이프라인에서 혁신성이 높은 중요한 부문으로 남을 것으로 보입니다.

부문

분자 유형(알카로이드, 페놀산, 테르페노이드, 안토시아닌, 기타 분자 유형), 최종사용자(바이오의약품 기업 최종사용자, 식이보충제 기업 최종사용자, 허브 기반 산업 최종사용자, 기타 최종사용자)

조사 대상 기업 예(총 42개사)

  • Alchem International Pvt. Ltd.
  • Antheia Inc.
  • Aurobindo Pharma Ltd.
  • Axplora
  • BOC Sciences
  • CBDepot
  • Dr. Reddy's Laboratories Ltd.
  • DuPont de Nemours, Inc.
  • Farmak a.s.
  • Jungbunzlauer Suisse AG
  • KD Pharma Group
  • Laurus Labs Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqens SAS
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.

관세 영향 계수

이번 보고서는 세계 산업 분석가들이 본사 소재지, 제조 기지, 수출 및 수입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고, 지리적 시장에 대한 관세의 영향을 반영하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 판매 비용 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁업체에 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 <>& 중국 <>& 멕시코 <>& 캐나다 <>&EU <>& 일본 <>& 인도 <>& 기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황에서 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 최고 이코노미스트를 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.06.17

Global Natural APIs Market to Reach US$40.8 Billion by 2030

The global market for Natural APIs estimated at US$30.9 Billion in the year 2024, is expected to reach US$40.8 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Alkaloids, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$18.8 Billion by the end of the analysis period. Growth in the Phenolic Acids segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.4 Billion While China is Forecast to Grow at 8.8% CAGR

The Natural APIs market in the U.S. is estimated at US$8.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.6 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Natural APIs Market - Key Trends & Drivers Summarized

Why Are Natural Active Pharmaceutical Ingredients Regaining Strategic Relevance in Modern Drug Development?

Natural active pharmaceutical ingredients (APIs), derived from plants, microbes, marine sources, and animals, are witnessing a resurgence in global pharmaceutical development due to their proven therapeutic efficacy, structural diversity, and alignment with green chemistry principles. Unlike fully synthetic APIs, which are manufactured through complex organic synthesis, natural APIs are extracted and purified from biological sources, often using solvent extraction, supercritical fluid methods, or fermentation. This origin lends credibility and acceptance to many natural-origin drugs, especially in pain, oncology, anti-infective, cardiovascular, and metabolic categories.

Historically, landmark drugs such as paclitaxel (from the Pacific yew tree), artemisinin (from Artemisia annua), and lovastatin (from Aspergillus terreus) have demonstrated the potential of natural APIs to transform therapeutic landscapes. With rising antibiotic resistance, cancer complexity, and the need for novel scaffolds in drug discovery, natural APIs offer a bioactive reservoir unmatched by purely synthetic libraries. Their integration into pharmaceutical pipelines-either as primary agents or lead structures for semisynthetic modifications-is being revitalized by advances in extraction technology, metabolomics, and computational biology.

How Are Sourcing Strategies, Green Extraction, and Regulatory Advances Enhancing Natural API Development?

Modern natural API manufacturing emphasizes traceable sourcing, solvent-free or minimal-solvent processing, and sustainability across the supply chain. Cultivated biomass, plant cell cultures, marine aquaculture, and microbial fermentation are being employed to ensure consistency, reduce environmental impact, and stabilize raw material supply. Technologies such as supercritical CO2 extraction, enzyme-assisted hydrolysis, and microwave-assisted extraction are being adopted to enhance yield, purity, and environmental compliance.

Regulatory frameworks in the U.S., EU, Japan, and emerging markets are evolving to accommodate natural APIs through phytopharmaceutical, botanical drug, and traditional medicine pathways. WHO and EMA guidelines now provide clear expectations for quality control, pharmacological characterization, and safety validation. The ability to comply with GMP, ICH Q7, and pharmacopoeial monographs is becoming critical for global commercialization. Standardization of extracts, batch-to-batch reproducibility, and stability profiling are areas of heightened focus as companies aim to scale production while maintaining bioactivity and compliance.

Which Therapeutic Categories and Markets Are Fueling Demand for Natural API-Based Drugs?

Natural APIs are seeing high demand in oncology, infectious disease, inflammation, gastrointestinal health, cardiometabolic disorders, and dermatology. Plant alkaloids, flavonoids, saponins, and terpenoids form the backbone of many anticancer and anti-inflammatory formulations. Antibiotic and antifungal agents derived from microbial fermentation, such as rifampin and amphotericin B, remain essential in infectious disease treatment. Cardiovascular drugs like digoxin (from Digitalis) and antimalarials like quinine continue to rely on naturally sourced APIs or their analogs.

Asia-Pacific remains the largest consumer and producer of natural APIs, owing to the region’s deep-rooted tradition in herbal medicine and extensive biodiversity. India and China dominate export and formulation activity, supplying APIs for both prescription drugs and phytopharmaceuticals. North America and Europe are witnessing growing demand for natural APIs in the context of clean-label pharmaceuticals, integrative medicine, and botanical drug development. Regulatory support for botanical pathways in the U.S. and consumer interest in nature-derived medicines are reinforcing demand in these mature markets.

What Is Driving Long-Term Growth and Innovation in the Natural APIs Market?

The growth in the natural APIs market is driven by increasing demand for nature-derived medicines, sustainability regulations, and drug discovery bottlenecks in synthetic chemistry. Pharmaceutical firms are revisiting natural product libraries through high-throughput screening, AI-driven compound mining, and ethnopharmacological databases. Collaborations between pharma companies, botanical research institutes, and biotech startups are yielding novel scaffolds, hybrid APIs, and new therapeutic indications for traditional compounds.

Investment in biotechnological synthesis of natural APIs-using engineered microbes or plant cells-is enabling scalability, environmental stewardship, and intellectual property protection. Advances in omics technologies, bioinformatics, and molecular docking are accelerating lead identification and SAR (structure-activity relationship) modeling for natural products. As consumer preference for natural health solutions grows alongside the pharmaceutical industry’s need for novel therapeutic agents, natural APIs will remain a vital, innovation-rich segment in global drug development pipelines.

SCOPE OF STUDY:

The report analyzes the Natural APIs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Molecule Type (Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin, Other Molecule Types); End-Use (Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alchem International Pvt. Ltd.
  • Antheia Inc.
  • Aurobindo Pharma Ltd.
  • Axplora
  • BOC Sciences
  • CBDepot
  • Dr. Reddy's Laboratories Ltd.
  • DuPont de Nemours, Inc.
  • Farmak a.s.
  • Jungbunzlauer Suisse AG
  • KD Pharma Group
  • Laurus Labs Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqens SAS
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Natural APIs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Demand for Plant-Based Pharmaceuticals Spurs Growth in Natural API Production
    • Consumer Shift Toward Herbal and Ayurvedic Formulations Expands Addressable Market
    • Stringent EU and US Pharmacopoeia Standards Strengthen Compliance Needs for Natural APIs
    • Increased Investment in Botanical Drug R&D Propels Innovation in API Extraction and Isolation
    • Growth of Clean Label Preferences in Pharmaceuticals Drives Demand for Natural Actives
    • Challenges in Standardization of Active Constituents Create Formulation Complexity
    • Expansion of Organic and Non-GMO Certified Ingredients Strengthens Sustainability Credentials
    • Widening Scope of APIs from Marine, Fungal, and Insect Sources Fuels Compound Diversification
    • Rising Trend of Ethnobotanical Research Supports Novel Drug Discovery Using Traditional Knowledge
    • Proliferation of Natural API Use in Nutraceuticals and Functional Foods Broadens Market Horizons
    • Development of Solvent-Free Extraction Methods Enhances Eco-Friendly Production Capabilities
    • Integration of Blockchain and AI in Supply Chains Enhances Traceability and Regulatory Readiness
    • Growing Collaborations Between Academic Institutions and API Producers Accelerate Compound Commercialization
    • Shortage of Wildcrafted Sources Poses Sustainability and Ethical Sourcing Challenges
    • Expansion of Natural API Use in Topical Therapeutics Spurs Growth in Dermatological Applications
    • Use of Supercritical CO? and Ultrasonic Extraction Drives Efficiency Gains in API Yield
    • Rising Clinical Evidence for Natural Compounds Enhances Therapeutic Credibility and Physician Adoption
    • Complex Regulatory Approvals for Botanical Drugs Pose Challenges for Market Entry
    • Increased Emphasis on Bioavailability Enhancers Spurs Innovation in Natural API Delivery Systems
    • Global Push for Reduced Environmental Footprint Favors Green Chemistry Processes in API Production
    • Growing Preference for Localized Sourcing Models Strengthens Resilience in Supply Chain Strategies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Natural APIs Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Natural APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Natural APIs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Natural APIs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Alkaloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Alkaloids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Alkaloids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Phenolic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Phenolic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Phenolic Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Terpenoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Terpenoids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Terpenoids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Anthocyanin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Anthocyanin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Anthocyanin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Molecule Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Molecule Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Molecule Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nutraceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nutraceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nutraceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Herbal-based Industries End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Herbal-based Industries End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Herbal-based Industries End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Natural APIs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Natural APIs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Natural APIs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Natural APIs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Natural APIs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Natural APIs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Natural APIs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Natural APIs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Natural APIs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Natural APIs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Natural APIs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Natural APIs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Natural APIs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Natural APIs by Molecule Type - Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Natural APIs by Molecule Type - Percentage Breakdown of Value Sales for Alkaloids, Phenolic Acids, Terpenoids, Anthocyanin and Other Molecule Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Natural APIs by End-Use - Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Natural APIs by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Nutraceutical Companies End-Use, Herbal-based Industries End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제